News

Medical Dialogues1h
AstraZeneca Imfinzi approved in EU for muscle-invasive bladder cancer
Cambridge: AstraZeneca has received approval for Imfinzi (durvalumab) in the European Union (EU) for the treatment of adult ...
How YOU can profit from Europe's sweltering summer. As our environment heats up, these funds could deliver sizzling returns: MIDAS SHARE TIPS
As Britain sweltered in the hottest June on record, businesses and homeowners invested in technology to make our living ...
PipelineReview.com21h
Imfinzi approved in the EU as first and only perioperative immunotherapy for muscle-invasive bladder cancer
Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the ...